![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 9/32 | |
A61K 9/36 | |||
A61K 9/16 | |||
A61K 9/24 | |||
A61K 9/26 |
(11) | Patento numeris | 2063872 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 07801970.0 |
Europos patento paraiškos padavimo data | 2007-08-29 | |
(97) | Europos patento paraiškos paskelbimo data | 2009-06-03 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2015-05-06 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/EP2007/007549 |
Data | 2007-08-29 |
(87) | Numeris | WO 2008/025535 |
Data | 2008-03-06 |
(30) | Numeris | Data | Šalis |
824043 P | 2006-08-30 | US | |
824054 P | 2006-08-30 | US |
(72) |
VERGNAULT, Guy, FR
GRENIER, Pascal, FR
NHAMIAS, Alain, FR
|
(73) |
Jagotec AG,
Eptingerstrasse 51, 4132 Muttenz,
CH
|
(54) | CONTROLLED RELEASE ORAL DOSAGE FORMULATIONS COMPRISING A CORE AND ONE OR MORE BARRIER LAYERS |
CONTROLLED RELEASE ORAL DOSAGE FORMULATIONS COMPRISING A CORE AND ONE OR MORE BARRIER LAYERS |